4 Comments

The most enthusiastic uptake on the pseudo-vaccine comes from the highly educated, some of whom do genuinely valuable work. Valuable to plutocrats. This is going to wreak havoc on the productivity of that class, and make their care very expensive. I don't necessarily disagree with you, but this looks like eugenics designed by idiots, who can't think past any one stage of their programme.

Expand full comment

Do you have any references to support your contention that an “AIDS czar at the National Institute of Health” bought Castro real estate? There were a parade of AIDS czars. Which one do you mean?

Expand full comment

Maybe you mean "Sotrovimab", not Remdesivir? Sotrovimab is the new monoclonal antibody product that they are hailing as a miracle cure, only available in Australia for early treatment (which is appropriate) for people who test positive & are considered high risk, eg with diabetes.

Remdesivir has been around since last year, & up until recently was the only TGA approved treatment for CV. It is not a monoclonal antibody product, but it is an antiviral - it showed slight shortening of hospitalisation when administered early (which it is not, here in Australia - it is only used for hospitalised patients). Less effective & more adverse reactions than HCQ - but hey, it's a new drug and still in patent so they can charge a lot for it.

But in essence, you are right, both are quite risky drugs & just another facet of the genocide project.

Expand full comment